Development of fluorescence-labeled antibody for immune checkpoint inhibitor using engineered probiotics

Here, we developed a genetically modified lactic acid bacteria (gmLAB) that produces green fluorescent protein (GFP)-conjugating, anti-programmed death-ligand 1 (PD-L1) single-chain variable fragments (scFv) for use as an anti-cancer device that targets immune checkpoint molecules. Since PD-L1 plays...

Descripción completa

Detalles Bibliográficos
Autores principales: Namai, Fu, Sumiya, Shunsuke, Nomura, Natsumi, Sato, Takashi, Shimosato, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837357/
https://www.ncbi.nlm.nih.gov/pubmed/36635518
http://dx.doi.org/10.1186/s13568-023-01509-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837357/
https://www.ncbi.nlm.nih.gov/pubmed/36635518
http://dx.doi.org/10.1186/s13568-023-01509-y

Ejemplares similares